Supporting Adult Immunization Awareness and Action

Understanding RSV across the life course

What is RSV?

Respiratory syncytial virus (RSV) is a common virus that infects the respiratory tract, from the nose to the lungs (World Health Organization). It often causes cold-like symptoms, including a runny nose, cough, sneezing and fever; most infections resolve on their own within one or two weeks (CDC symptoms and care).

RSV is not just a childhood illness: people can be infected again throughout life (CDC transmission guidance). It can spread through coughs and sneezes, close contact, and touching contaminated surfaces before touching your face (CDC transmission guidance).

Why RSV matters for adults

RSV can be more than a cold, particularly for older adults and people living with chronic heart or lung disease or weakened immune systems (CDC RSV in adults). It can cause pneumonia, lead to hospitalization and worsen conditions such as asthma, COPD and heart failure (CDC RSV in adults).

Research helps show the scale of this burden:

Hospitalization

A systematic review and meta-analysis estimated that RSV caused approximately 470,000 hospitalizations among adults aged 60 and older in high-income countries in 2019 (Savic and colleagues, 2023).

COPD

A 2025 systematic review found that approximately 31% of adults hospitalized with RSV had underlying COPD. (Penders and colleagues, 2025).

Asthma

The same review found that approximately 19% of adults hospitalized with RSV had underlying asthma. (Penders and colleagues, 2025).

RSV in babies and young children

Most children have had RSV by their second birthday, and while many have a mild illness, RSV can cause bronchiolitis, an inflammation of the small airways, or pneumonia (CDC RSV in infants and young children). The youngest infants, babies born prematurely and children with certain heart, lung or immune conditions are at increased risk of severe illness (CDC RSV in infants and young children).

Estimates for 2019 cited by WHO put the worldwide annual burden at approximately 3.6 million RSV-associated hospitalizations and 100,000 RSV-attributable deaths among children under five (WHO RSV fact sheet). Approximately 97% of RSV deaths in children occur in low- and middle-income countries, highlighting the importance of equitable access to prevention and care (WHO RSV fact sheet).

Protection can begin during pregnancy

RSV protection for a baby can begin before birth through maternal vaccination, or after birth through a long-acting antibody immunization given to the infant (WHO RSV fact sheet). These are different approaches to helping prevent severe RSV illness in early life:

Maternal vaccination

An RSV vaccine given during pregnancy allows protective antibodies to pass through the placenta to the baby, helping provide protection during the first months after birth (WHO RSV fact sheet).

Infant antibody immunization

A long-acting monoclonal antibody given directly to the baby provides ready-made protection; it is not a vaccine (WHO RSV fact sheet).

Most infants do not need both maternal vaccination and infant antibody immunization (CDC RSV in infants and young children). Ask your maternity or child healthcare team which option is appropriate and available where you live, and when it should be given.

Patient and family tips: understand your risk and take action

Through patient-centred education, collaboration and advocacy, the Alliance aims to help people understand their immunization options, support conversations with healthcare professionals and address barriers to access. Its work connects patient experience with practical action at community, health system and policy levels.

Start an immunization conversation

Ask your healthcare professional which vaccines are recommended for you, including whether an RSV vaccine is appropriate, and discuss local eligibility and access (CDC respiratory illness prevention).

Plan protection for your baby

During pregnancy, ask about maternal RSV vaccination and infant antibody options, so you can discuss a protection plan before your baby is born (WHO RSV fact sheet).

Use everyday prevention steps

Wash or sanitize your hands regularly, cover coughs and sneezes, and clean frequently touched surfaces (CDC transmission guidance).

Think about air and close contact

Bring in fresh air or meet outdoors where possible, and stay home and away from others when you are sick; masks and physical distancing can provide additional protection (CDC transmission guidance).

Know the symptoms

Watch for a runny nose, congestion, cough, sneezing, fever or wheezing, and contact your healthcare professional if symptoms worsen (CDC symptoms and care).

Seek help promptly

Contact your healthcare professional if you have difficulty breathing, trouble drinking enough fluids, chest pain or pressure, sudden dizziness or confusion, or worsening symptoms (CDC RSV in adults).

Watch for changes in your baby

Very young infants may feed less, be less active or irritable, or have pauses in breathing; they may not have a fever (CDC RSV in infants and young children).

Get medical help for your child

Seek prompt medical attention for difficulty breathing, not drinking enough fluids or worsening symptoms; pauses in breathing need urgent assessment (CDC RSV in infants and young children).

Use this information to prepare questions for your healthcare team, not to replace individual medical advice. Follow vaccination recommendations and care guidance in your country or region.

About us

The Immunization Alliance supports a coordinated approach to adult immunization, focusing on adults living with asthma, chronic obstructive pulmonary disease (COPD) and cardiovascular disease.

Through patient-centred education, collaboration and advocacy, the Alliance aims to help people understand their immunization options, support conversations with healthcare professionals and address barriers to access. Its work connects patient experience with practical action at community, health system and policy levels.

Our focus

The Alliance’s scope includes immunization against five priority diseases:

COVID-19
Respiratory syncytial virus (RSV)
Influenza
Pneumococcal disease
Herpes zoster (shingles)

Our aim is to support a more connected conversation about adult immunization, rather than considering each vaccine in isolation. This is not a recommendation that every adult receive every vaccine: recommendations and availability vary by country, age, health condition and individual circumstances.

Speak with your healthcare professional about which immunizations are appropriate for you. Follow the current recommendations in your country or region.

Our vision

A world where adults living with chronic conditions can access clear information, discuss immunization confidently with their healthcare teams and obtain recommended vaccines. We want prevention to be part of ongoing care, with patient experience helping shape how services are designed and delivered and promote a life-course approach to healthy immune systems.

What we are working towards

Social Media Content

Help spread the word about RSV risks by sharing this content on social media.

2026
Suggested messaging

RSV isn’t just a baby thing. It can affect us at every age.

RSV (respiratory syncytial virus) is a common virus that infects the lungs and airways. Each year, it sends about 3.6 million young children to hospital around the world.¹ In wealthier countries alone, it also puts about 470,000 adults over 60 in hospital.²

Babies, older adults and people with lung conditions like asthma and COPD are most at risk.

The good news? We now have ways to protect people at almost every stage of life.

This RSV Awareness Week, GAAPP is asking for RSV protection that covers the whole life course: before birth, in babyhood, and in adulthood.

🔗 Learn more and share this RSV Awareness Week: gaapp.org/immunization

This content was developed by GAAPP (Global Allergy & Airways Patient Platform) to raise awareness of RSV across the life course. It’s for general information only. Always talk to your healthcare provider about your own health.
References: 1. WHO. Respiratory syncytial virus (RSV) fact sheet. https://www.who.int/news-room/fact-sheets/detail/respiratory-syncytial-virus-(rsv); 2. Savic M, et al. RSV disease burden in adults aged 60 years and older in high-income countries. Influenza Other Respir Viruses. 2023. https://onlinelibrary.wiley.com/doi/abs/10.1111/irv.13031
#RSVAwarenessWeek #LifeCourseImmunization #LungHealth #RSVIsNotJustABabyThing

Suggested messaging

Protecting babies from RSV can start before they’re born, and it may even help their lungs for life. 🤰

About half of RSV deaths in children happen in babies under 6 months old.¹ That’s why the World Health Organization (WHO) wants every country to offer one of two options:²

  • An RSV vaccine during pregnancy (from about 28 weeks). The parent passes protection to the baby before birth.¹
  • A long-lasting antibody shot for the baby, given at birth or before RSV season. It protects for at least 5 months.¹

There may be a bonus too. In a US study of more than 1,900 babies, kids who didn’t catch RSV in their first year were 26% less likely to have asthma by age 5.³ This shows a link, not proof, and research is ongoing.

Most child RSV deaths (97%) happen in low- and middle-income countries.¹ Every baby deserves protection, wherever they are born.

This RSV Awareness Week, GAAPP is asking health systems to make RSV protection a normal part of pregnancy and newborn care.

🔗 Learn more at gaapp.org/immunization

This content was developed by GAAPP (Global Allergy & Airways Patient Platform) to raise awareness of RSV across the life course. It’s for general information only. Always talk to your healthcare provider about your own health.
References: 1. WHO. Respiratory syncytial virus (RSV) immunization products: questions and answers. https://www.who.int/news-room/questions-and-answers/item/respiratory-syncytial-virus-(rsv)-immunization-products; 2. WHO. Position paper on immunization to protect infants against RSV disease, May 2025. https://www.who.int/publications/i/item/who-wer-10022-193-218; 3. Rosas-Salazar C, et al. RSV infection during infancy and asthma during childhood (INSPIRE). Lancet. 2023;401:1669-80. Summary: https://www.nih.gov/news-events/nih-research-matters/avoiding-rsv-infancy-reduces-asthma-risk
#RSVAwarenessWeek #LifeCourseImmunization #LungHealth #RSVIsNotJustABabyThing

Suggested messaging

Vaccines are a big part of RSV protection, but everyday habits matter too. 🧼

RSV spreads through coughs, sneezes and touching surfaces that have the virus on them. Simple steps can lower the risk for you and the people around you:¹

  • Wash or sanitize your hands often.
  • Cover your coughs and sneezes.
  • Clean surfaces that get touched a lot, like phones, door handles and toys.
  • Let in fresh air or meet outdoors when you can.
  • Stay home and away from others when you’re sick.

For babies, two more steps help. Keep them away from people who are sick, and keep them away from cigarette smoke. Second-hand smoke raises the risk of RSV and can make it more serious.²

This RSV Awareness Week, GAAPP has a message for workplaces, schools and daycares. When people can stay home sick, everyone is safer.

🔗 Learn more at gaapp.org/immunization

This content was developed by GAAPP (Global Allergy & Airways Patient Platform) to raise awareness of RSV across the life course. It’s for general information only. Always talk to your healthcare provider about your own health.
References: 1. CDC. How RSV spreads and how to protect yourself. https://www.cdc.gov/rsv/causes/index.html; 2. BC Centre for Disease Control. Respiratory syncytial virus (RSV). https://www.bccdc.ca/health-info/diseases-conditions/respiratory-syncytial-virus
#RSVAwarenessWeek #LifeCourseImmunization #LungHealth #RSVIsNotJustABabyThing

Suggested messaging

Living with asthma or COPD? RSV can be much more than a cold. Here’s how to lower your risk, and what to do if you get sick.

RSV hits people with lung conditions harder. Out of every 100 adults in hospital with RSV, about 31 had COPD and 19 had asthma.¹ RSV can make asthma and COPD worse and lead to attacks or flare-ups.²

Lower your risk:

  • Keep taking your daily medicines as prescribed
  • Have an up-to-date action plan and know how to use it³
  • Wash your hands and avoid close contact with people who are sick
  • Ask your healthcare provider if an RSV vaccine is right for you. It depends on where you live.⁴

Know the signs: RSV often starts like a cold, with a runny nose, cough, fever or wheezing.²

If you get sick, follow your action plan and call your healthcare provider early if your breathing gets worse or you have a fever.³ ⁵ Don’t wait. Early care can help stop a flare-up from getting serious.

This RSV Awareness Week, GAAPP is asking healthcare providers to talk with every patient with asthma or COPD about RSV.

🔗 Find patient resources at gaapp.org/immunization

This content was developed by GAAPP (Global Allergy & Airways Patient Platform) to raise awareness of RSV across the life course. It’s for general information only. Always talk to your healthcare provider about your own health.
References: 1. Burden of RSV disease in adults with asthma or COPD: a systematic review. Curr Allergy Asthma Rep. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11850418/; 2. CDC. Symptoms of RSV. https://www.cdc.gov/rsv/symptoms/index.html; 3. Mayo Clinic. Asthma: limit asthma attacks caused by colds or flu. https://www.mayoclinic.org/diseases-conditions/asthma-attack/in-depth/asthma/art-20043943; 4. CDC. Clinical guidance for RSV vaccines in adults. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html; 5. NHLBI. Living with COPD. https://www.nhlbi.nih.gov/health/copd/living-with
#RSVAwarenessWeek #LifeCourseImmunization #LungHealth #RSVIsNotJustABabyThing

Suggested messaging

Protecting people from RSV at every stage of life looks like this:
🤰 Pregnancy: a vaccine to protect the newborn.¹
👶 Babies: an antibody shot at birth or before RSV season.¹
🫁 Adults with asthma, COPD or other long-term illness: a vaccine, if it’s offered.²
👵 Older adults: a vaccine, if it’s offered.²

Each stage helps the next. Protecting babies may help keep their lungs healthy for life.³ Protecting adults with asthma and COPD can help prevent flare-ups and hospital stays.

This RSV Awareness Week, GAAPP is asking governments to offer RSV protection for every age. Every family should be able to get it. That includes families in low- and middle-income countries, where 97% of child RSV deaths happen.¹

How does your country protect people from RSV? Tell us in the comments! 👇

🔗 Learn more and get involved at gaapp.org/immunization

This content was developed by GAAPP (Global Allergy & Airways Patient Platform) to raise awareness of RSV across the life course. It’s for general information only. Always talk to your healthcare provider about your own health.
References: 1. WHO. Respiratory syncytial virus (RSV) immunization products: questions and answers. https://www.who.int/news-room/questions-and-answers/item/respiratory-syncytial-virus-(rsv)-immunization-products; 2. CDC. Clinical guidance for RSV vaccines in adults. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html; 3. Rosas-Salazar C, et al. RSV infection during infancy and asthma during childhood (INSPIRE). Lancet. 2023;401:1669-80. Summary: https://www.nih.gov/news-events/nih-research-matters/avoiding-rsv-infancy-reduces-asthma-risk
#RSVAwarenessWeek #LifeCourseImmunization #LungHealth #RSVIsNotJustABabyThing

2025

References

  1. Centers for Disease Control and Prevention (CDC). Symptoms and Care of RSV. Accessed October 2025. https://www.cdc.gov/rsv/symptoms/index.html
  2. Centers for Disease Control and Prevention (CDC). RSV in Infants and Young Children. Accessed October 2025. RSV in Infants and Young Children | RSV | CDC. Accessed October 2025. https://www.cdc.gov/rsv/infants-young-children/index.html
  3. World Health Organization (WHO). Respiratory Syncytial Virus (RSV) Fact Sheet. Accessed October 2025. https://www.who.int/news-room/fact-sheets/detail/respiratory-syncytial-virus-%28rsv%29
  4. Centers for Disease Control and Prevention (CDC). Preliminary Estimates of RSV Burden for 2024–2025. Accessed October 2025. https://www.cdc.gov/rsv/php/surveillance/burden-estimates.html
  5. Centers for Disease Control and Prevention (CDC). Clinical Overview of RSV. Accessed October 2025. https://www.cdc.gov/rsv/hcp/clinical-overview/index.html
  6. National Institutes of Health (NIH), National Library of Medicine. Respiratory Syncytial Virus Infection in Older Adults: An Update. Published July 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11193699/
  7. Centers for Disease Control and  Prevention (CDC). How RSV Spreads. Accessed October 2025. https://www.cdc.gov/rsv/causes/
  8. BMC Medicine. Estimating the Respiratory Syncytial Virus-Associated Hospitalization Burden in Older Adults: A Systematic Review. Published August 2025. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-025-04249-x